Despite post-operative adjuvant therapy based on the pathology, status of axillary lymph nodes, tumor size and status of hormone receptors in breast cancer patients [2], [23], more than 15% of patients develop incurable disease [3]. Here, NR4A1 is linked to breast cancer.